McVannel Taylor, Tangedal Kirsten, Haines Aleina, Semchuk William M
, BScPharm, ACPR, was, at the time of this study, a Pharmacy Resident with the Department of Pharmacy Services, Saskatchewan Health Authority, Regina, Saskatchewan. She is now with the Department of Pharmacy Services, Brandon Regional Health Centre - Prairie Mountain Health, Brandon, Manitoba.
, BSP, ACPR, is with the Department of Pharmacy Services, Saskatchewan Health Authority, Regina, Saskatchewan.
Can J Hosp Pharm. 2023 Mar 1;76(2):126-130. doi: 10.4212/cjhp.3276. eCollection 2023 Spring.
Clinical pharmacy key performance indicators (cpKPIs) relate to activities performed by pharmacists that have been shown to improve patient outcomes. Within Saskatchewan Health Authority (SHA) Regina, most cpKPIs are incorporated into the organization's clinical practice standards, which provide guidance in prioritizing care, especially for high-risk medications, including anticoagulants. To track pharmacists' interventions associated with clinical practice standards, a locally developed electronic data-capture system (known as AIM High) was implemented.
To quantify and describe pharmacists' anticoagulation interventions on 16 wards with dedicated ward-based clinical pharmacists and to compare intervention rates between the cardiology and internal medicine wards to further evolve the organization's practice model.
Data from the electronic data-capture system were retrospectively analyzed for a 5-year period (January 2016 to December 2020).
A total of 94 201 interventions were recorded in the AIM High system (average 362 interventions per week or 26 interventions per pharmacist per week). Of these, 15 661 (16.6%) cited the anticoagulation standard (average 60 anticoagulation interventions per week or 4 anticoagulant interventions per pharmacist per week). For the cardiology and internal medicine wards, 4183 of 11 888 (35.2%) and 9034 of 54 843 (16.5%) interventions cited the anticoagulation standard, respectively. The top 4 types of anticoagulation interventions were dose changed ( = 4372 or 27.9%), drug started or restarted ( = 3867 or 24.7%), patient education ( = 3094 or 19.8%), and drug discontinued ( = 2944 or 18.8%).
Dedicated ward-based clinical pharmacists were following clinical practice standards incorporating the majority of cpKPIs to complete anticoagulation interventions. The types of anticoagulation interventions evolved over time and were influenced by the patient population.
临床药学关键绩效指标(cpKPIs)与药剂师开展的已被证明能改善患者预后的活动相关。在萨斯喀彻温省卫生局(SHA)里贾纳地区,大多数cpKPIs已纳入该组织的临床实践标准,这些标准为确定护理优先级提供指导,尤其是对于包括抗凝剂在内的高风险药物。为追踪与临床实践标准相关的药剂师干预措施,实施了一个本地开发的电子数据采集系统(称为AIM High)。
量化并描述在设有专职病房临床药剂师的16个病房中医剂师的抗凝干预措施,并比较心脏病科和内科病房的干预率,以进一步完善该组织的实践模式。
对电子数据采集系统5年期间(2016年1月至2020年12月)的数据进行回顾性分析。
AIM High系统共记录了94201次干预措施(平均每周362次干预,或每位药剂师每周26次干预)。其中,15661次(16.6%)引用了抗凝标准(平均每周60次抗凝干预,或每位药剂师每周4次抗凝干预)。在心脏病科和内科病房,分别有11888次干预中的4183次(35.2%)和54843次干预中的9034次(16.5%)引用了抗凝标准。抗凝干预的前4种类型为剂量改变(=4372次或27.9%)、药物开始或重新开始使用(=3867次或24.7%)、患者教育(=3094次或19.8%)以及药物停用(=2944次或18.8%)。
专职病房临床药剂师遵循纳入大多数cpKPIs的临床实践标准来完成抗凝干预措施。抗凝干预的类型随时间演变,并受患者群体的影响。